NCT04330014

Brief Summary

The aim of study to evaluate the factor affecting underutalization of childhood vaccination immunization among childern below two years of age.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 1, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

January 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

April 1, 2020

Status Verified

March 1, 2020

Enrollment Period

1 year

First QC Date

March 30, 2020

Last Update Submit

March 31, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison between childern below two years who took vaccinations and those who didnot.

    The investigators evaluate factors effect of vaccine on the child as scioeconomic status, poverty, chronic disease and residance.

    Baseline

Interventions

vaccineBEHAVIORAL

affect vaccination on children

Eligibility Criteria

Age1 Month - 2 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

childern below two years

You may qualify if:

  • All childern in first two years of life who admmitted in hospital or out patient clinic.

You may not qualify if:

  • : Immunodeficiency (e.g chemotherapy,long term immuno suppressive therapy, hematologic tumor).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Interventions

Vaccines

Intervention Hierarchy (Ancestors)

Biological ProductsComplex Mixtures

Study Officials

  • Mohamed Mahmoud, professor

    Assiut University

    PRINCIPAL INVESTIGATOR
  • Ismail Lotfy, professor

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gehad Gamal, master

CONTACT

Gehad Gamal, master

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

March 30, 2020

First Posted

April 1, 2020

Study Start

January 1, 2021

Primary Completion

January 1, 2022

Study Completion

May 1, 2022

Last Updated

April 1, 2020

Record last verified: 2020-03